Clinical evaluation of glibornuride (glutril): a new oral antidiabetic drug.
D000328:Adult; D000368:Aged; D001786:Blood Glucose; D001794:Blood Pressure; D001798:Blood Proteins; D001892:Camphanes / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*
D001786:Blood Glucose; D001798:Blood Proteins; D001892:Camphanes; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds